A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Clinical trial NCT05050942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05050942
- Sponsor
- Camurus AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2026-11-01
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.